CytomX Therapeutics Inc (CTMX) with a beta value of 1.07 appears to be a promising investment opportunity.
CytomX Therapeutics Inc (NASDAQ: CTMX) kicked off on Friday, down -3.47% from the previous trading day, before settling in for the closing price of $1.73.